(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DELCETRAVIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DELCETRAVIR

ST13

US500000079331699

Class

5

Filing

79331699

Registration

7307186

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

11/01/2024

Trademark type

Word

Nice classes

5

Filing date

12/22/2021

Registration date

02/20/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/20/2024

Last transaction

02/20/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

AU

Examiner

GARDNER, BERYL

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Esfam Biotech Pty Ltd

Representatives

Alana M. Fuierer Heslin Rothenberg Farley & Mesiti P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticalmedicinal and therapeutic medicinal preparations for human and animal useall for human and animal use for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; pharmaceutical preparations for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; pharmaceutical preparations for treatment or prevention of COVID-19coronavirus diseaserespiratory diseases and disorders; veterinary preparations for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; veterinary pharmaceutical preparations for treatment or prevention of infectious diseases including but not limited to respiratory diseases and disorders

Publications

History of USPTO decisions and trademark events.

30 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/01/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/27/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/06/2024

FIMP

FINAL DISPOSITION PROCESSED

07/05/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/21/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/20/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/05/2023

PUBO

PUBLISHED FOR OPPOSITION

12/05/2023

GPNX

NOTIFICATION PROCESSED BY IB

12/03/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/15/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/15/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/31/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/21/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

06/28/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/27/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/06/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/06/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/06/2022

RFNT

REFUSAL PROCESSED BY IB

07/19/2022

DOCK

ASSIGNED TO EXAMINER

07/07/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/30/2022

RFRR

REFUSAL PROCESSED BY MPU

06/30/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/28/2022

CNRT

NON-FINAL ACTION WRITTEN

06/27/2022

DOCK

ASSIGNED TO EXAMINER

06/22/2022

MAFR

APPLICATION FILING RECEIPT MAILED

02/01/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/28/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/27/2022

Continuous trademark protection

Get notified about every new filing that threatens DELCETRAVIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.